RPG Life Sciences Ltd (RPGLIFE) — Corporate Action | 26 September 2026

26 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Scheme of amalgamation approved between Actis Generics and RPG Active Pharma

🔄 What Changed

Consolidation of assets and liabilities; streamlined corporate structure; cost savings; stronger balance sheet

🔮 What's Next

NCLT approval and shareholder consent required before effectiveness

💡 Investor Takeaway

This merger simplifies the corporate structure and may improve long-term financial health without altering current shareholding.

RPG Life Sciences announced a scheme to amalgamate its wholly owned subsidiary Actis Generics with RPG Active Pharma, consolidating assets and liabilities to streamline structure, reduce costs, and strengthen the balance sheet. The transaction is a related-party amalgamation requiring NCLT approval and shareholder consent, with no change to the listed company's shareholding pattern.

📄 View Original Announcement (PDF)

📊 Stock Analysis — RPGLIFE ✨ Ask AI About This

About RPG Life Sciences Ltd (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,883.64 CrP/E: 40.8ROE: 19.8%ROCE: 25.8%Div Yield: 0.81%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

💡 Ask AI about this filing

"How will the combined entity's valuation compare to peers?""What specific cost savings targets have been set?""When will NCLT approval be finalized?"

Ask AI Free →

📊 More RPGLIFE filings

Announcement — 25 September 2026RPG Life Sciences Ltd announced that its insider trading window will close on October 1, 2026, and r...
Announcement — 24 September 2026RPG Life Sciences completed its acquisition of Actis Generics Private Limited through a share purcha...
Announcement — 24 September 2026RPG Life Sciences clarified that the recent rise in trading volume is due to normal market condition...
🔴 Announcement — 17 September 2026RPG Life Sciences Ltd announced an analyst/investor meeting scheduled for September 22, 2026 at 10:0...
Announcement — 15 September 2026RPG Life Sciences announced completion of its subsidiary's business transfer agreement with Raghava ...

See all RPGLIFE filings →

🔥 Also filed on 26 September 2026

WHEELSWheels India LtdCorporate Action 530217Swojas Foods LtdInsider Trading NURECANureca LtdInsider Trading 540786Sharika Enterprises LtdCorporate Action CHOLAFINCholamandalam Investment & Finance Company LtdCorporate Action WELWonder Electricals LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.